Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial CTSUBRENB-43-M

Title

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUBRENB-43-M
  • Open Date: 04/26/2012
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: Breast
  • Therapies: Molecular Targeted Agents / Immunotherapy / Biologics; Radiotherapy
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: b-43

Description

None Provided.

Eligibility

Not provided. Please call for more information.